aryx therapeutics inc (ARYX:OTC US)

Financial Statements for aryx therapeutics inc (ARYX)

Currency in Millions of US Dollars	As of:	Dec 31 2006	Dec 31 2007	Dec 31 2008 Reclassified	Dec 31 2009	4 Year Trend
Revenues		4.7	4.2	19.7	--
TOTAL REVENUES		4.7	4.2	19.7	--
Cost of Goods Sold		2.1	0.3	0.2	--
GROSS PROFIT		2.6	3.9	19.5	--
Selling General & Admin Expenses, Total		6.9	7.7	10.1	10.2
R&D Expenses		24.0	25.0	39.8	21.0
OTHER OPERATING EXPENSES, TOTAL		30.9	32.7	49.9	31.2
OPERATING INCOME		-28.3	-28.8	-30.4	-31.2
Interest Expense		-1.3	-1.4	-1.9	-2.0
Interest and Investment Income		2.3	2.6	1.3	0.1
Gain (Loss) on Sale of Investments		--	--	-0.1	0.0
EBT, INCLUDING UNUSUAL ITEMS		-27.3	-27.6	-31.2	-33.2
Earnings from Continuing Operations		-27.3	-27.6	-31.2	-33.2
Extraordinary Item & Accounting Change		0.0	--	--	--
NET INCOME		-27.3	-27.6	-31.2	-33.2
NET INCOME TO COMMON INCLUDING EXTRA ITEMS		-27.3	-27.6	-31.2	-33.2
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS		-27.3	-27.6	-31.2	-33.2

Report Data Issue

To contact ARYX THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.